Paper Review Records
All Paper Review Records
21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Sex- and frequency-dependent acute pharmacokinetic and pharmacodynamic effects of smoked cannabis: a randomized controlled trial
Stephanie Lake; Elisa Pabon; Samantha L. Baglot; Alisha Eversole; Conor H. Murray; Katherine Hampilos; Timothy Fong; Holly Middlekauff; Margaret Haney; Suzette M. Evans; Adren Tran; Alexa Torrens; Daniele Piomelli; Ziva D. CooperShow moreShow less
1. UCLA Center for Cannabis and Cannabinoids, Jane and Terry Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, USA; 2. Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, USA; 3. Division of Cardiology, Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, USA; 4. New York State Psychiatric Institute, New York, USA; 5. Department of Psychiatry, Columbia University Irving Medical Center, New York, USA; 6. Department of Anatomy and Neurobiology, University of California, Irvine, USA; 7. Department of Biological Chemistry, UCI, Irvine, USA; 8. Department of Pharmaceutical Sciences, UCI, Irvine, USA; 9. Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, UCLA, Los Angeles, USAShow moreShow less
Sex differences in circulating endocannabinoid concentrations during adolescence: Associations with pubertal development
Julia M. Evanski; Tristin Smith; Adriene M. Beltz; Esmeralda Hidalgo-Lopez; Christel M. Portengen; Andrew Schrepf; Steven E. Harte; Chelsea M. KaplanShow moreShow less
1. Neuroscience Graduate Program, University of Michigan, Ann Arbor, USA; 2. Department of Anesthesiology, University of Michigan, Ann Arbor, USA; 3. Department of Psychology, University of Michigan, Ann Arbor, USA; 4. Survey Research Center in the Institute for Social Research, University of Michigan, Ann Arbor, USAShow moreShow less
Testing neurobiological models of reward/incentive sensitization in the continuation of alcohol use disorder (AUD) symptoms in young adults with AUD: A four-year longitudinal study
Andrea C. King; Rachel K. Nordgren; Dingcai Cao; Claire E. Wellendorf; Daniel J. FridbergShow moreShow less
1. The University of Chicago, Department of Psychiatry and Behavioral Neuroscience, Chicago, USA; 2. The University of Chicago, Department of Public Health Sciences, Chicago, USAShow moreShow less
Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response
Gabriele Floris; Sarah J. Jefferson; Jocelyne Rondeau; Abigail L. Yu; Frank S. Menniti; Alex C. Kwan; Joao P. De Aquino; John H. Krystal; Christopher Pittenger; Alfred P. KayeShow moreShow less
1. Yale University Department of Psychiatry, New Haven, USA; 2. Freedom Biosciences, Tiburon, USA; 3. George & Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, USA; 4. Meinig School of Biomedical Engineering, Cornell University, Ithaca, USA; 5. Department of Psychiatry, Weill Cornell Medicine, New York, USA; 6. Yale University Center for Brain Mind Health, New Haven, USA; 7. Yale University Department of Psychology, New Haven, USA; 8. Yale University Department of Neuroscience, New Haven, USA; 9. Yale University Child Study Center, New Haven, USA; 10. Yale University Department of Comparative Medicine, New Haven, USA; 11. Yale University Wu Tsai Institute, New Haven, USAShow moreShow less
A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD
Brooke L. Sevchik; S. Parker Singleton; Analiese Lahey; Pim Cuijpers; Mathias Harrer; Megan T. Jones; Sandeep M. Nayak; Eric C. Strain; Simon N. Vandekar; David B. Yaden; Robert H. Dworkin; J. Cobb Scott; Theodore D. SatterthwaiteShow moreShow less
1. Penn Lifespan Informatics and Neuroimaging Center, University of Pennsylvania, Philadelphia, USA; 2. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 3. Department of Clinical, Neuro and Developmental Psychology, WHO Collaborating Centre for Research and Dissemination of Psychological Interventions, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; 4. International Institute for Psychotherapy, Babeș-Bolyai University, Ciuj-Napoca, Romania; 5. Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, Amsterdam, The Netherlands; 6. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, USA; 7. Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, USA; 8. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, USA; 9. Departments of Anesthesiology and Perioperative Medicine and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, USA; 10. Department of Psychiatry, Brain Behavior Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 11. VISN4 Mental Illness Research, Education and Clinical Center, Crescenz VA Medical Center, Philadelphia, USA; 12. Penn-CHOP Lifespan Brain Institute, Perelman School of Medicine, Children’s Hospital of Philadelphia Research Institute, Philadelphia, USAShow moreShow less
Modulation of the noradrenergic system using transcranial ultrasonic stimulation targeted to the brainstem locus coeruleus in awake mice
Emma Lescrauwaet; Robrecht Raedt; Tom Plovie; Sielke Caestecker; Bethany Stieve; Sara Neyt; Thomas Tarnaud; Emmeric Tanghe; Keith Murphy; Evelien Carrette; Paul Boon; Kristl VonckShow moreShow less
1. 4BRAIN, Department of Neurology, Ghent University Hospital, Ghent, Belgium; 2. INTEC WAVES – IMEC, Department of Information Technology, Ghent University, Ghent, Belgium; 3. iBME-MEDISIP-Infinity Lab, Department of Electronics and Information Systems, Ghent University, Ghent, Belgium; 4. Department of Radiology, Stanford University, Palo Alto, USA; 5. Attune Neurosciences, Palo Alto, USAShow moreShow less
FAQ
How long does NEUROPSYCHOPHARMACOLOGY take to review a manuscript?
As of 2026-11-18, CrushSCI has 21 complete review records for NEUROPSYCHOPHARMACOLOGY. The fastest paper went from submission to acceptance in 2 days (Examining the impact of maternal oxycodone self-administration during gestation in a translational model, received 2026-05-13, accepted 2026-05-15); the slowest took 191 days. The average is 101.3 days and the median is 107 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
